Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy

Susan McKee, Howard Wu, Xiaoyan Wang, Harvey Cramer, Jingmei Lin, Shaoxiong Chen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: The aim of this study is to determine the risk of neoplasm and malignancy in thyroid fine needle aspiration (FNA) diagnosed as atypia of undetermined significance with Hürthle cell change (AUS-H) or Hürthle cell neoplasm (HCN). Study Design: A computerized search of our laboratory information system was performed to identify all thyroid FNA and correlating surgical pathology diagnoses including Hürthle cell or oncocyte in the diagnostic nomenclature. The risks of neoplasm and malignancy were calculated for AUS-H and HCN categories separately. Results: For the 29 AUS-H cases, the follow-up histology demonstrated 15 benign lesions, 4 follicular adenomas, 7 Hürthle cell adenomas, 1 papillary microcarcinoma (PMC), 1 follicular carcinoma and 1 Hürthle cell carcinoma. For the 93 HCN cases, the follow-up histology demonstrated 28 benign lesions, 9 follicular adenomas, 32 Hürthle cell adenomas, 2 PMCs, 2 papillary thyroid carcinomas, 6 follicular carcinomas and 14 Hürthle cell carcinomas. Conclusions: The risks of neoplasm and malignancy were 62 and 7% for the AUS-H category and 73 and 24% for the HCN category, respectively. The risk of malignancy for the AUS-H patients is within the 5- to 15-percent range suggested by the Bethesda System for Reporting Thyroid Cytology and within the 15- to 30-percent range suggested for follicular neoplasms.

Original languageEnglish
Pages (from-to)235-238
Number of pages4
JournalActa Cytologica
Volume58
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Fine Needle Biopsy
Neoplasms
Adenoma
Carcinoma
Thyroid Gland
Histology
Clinical Laboratory Information Systems
Surgical Pathology
Terminology
Cell Biology

Keywords

  • Fine needle aspiration
  • Hürthle cell neoplasm
  • Risk of malignancy
  • Thyroid

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

@article{9ac45da9994a4cbfa0b5472e54b7c567,
title = "H{\"u}rthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy",
abstract = "Objectives: The aim of this study is to determine the risk of neoplasm and malignancy in thyroid fine needle aspiration (FNA) diagnosed as atypia of undetermined significance with H{\"u}rthle cell change (AUS-H) or H{\"u}rthle cell neoplasm (HCN). Study Design: A computerized search of our laboratory information system was performed to identify all thyroid FNA and correlating surgical pathology diagnoses including H{\"u}rthle cell or oncocyte in the diagnostic nomenclature. The risks of neoplasm and malignancy were calculated for AUS-H and HCN categories separately. Results: For the 29 AUS-H cases, the follow-up histology demonstrated 15 benign lesions, 4 follicular adenomas, 7 H{\"u}rthle cell adenomas, 1 papillary microcarcinoma (PMC), 1 follicular carcinoma and 1 H{\"u}rthle cell carcinoma. For the 93 HCN cases, the follow-up histology demonstrated 28 benign lesions, 9 follicular adenomas, 32 H{\"u}rthle cell adenomas, 2 PMCs, 2 papillary thyroid carcinomas, 6 follicular carcinomas and 14 H{\"u}rthle cell carcinomas. Conclusions: The risks of neoplasm and malignancy were 62 and 7{\%} for the AUS-H category and 73 and 24{\%} for the HCN category, respectively. The risk of malignancy for the AUS-H patients is within the 5- to 15-percent range suggested by the Bethesda System for Reporting Thyroid Cytology and within the 15- to 30-percent range suggested for follicular neoplasms.",
keywords = "Fine needle aspiration, H{\"u}rthle cell neoplasm, Risk of malignancy, Thyroid",
author = "Susan McKee and Howard Wu and Xiaoyan Wang and Harvey Cramer and Jingmei Lin and Shaoxiong Chen",
year = "2014",
doi = "10.1159/000361073",
language = "English",
volume = "58",
pages = "235--238",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "3",

}

TY - JOUR

T1 - Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy

AU - McKee, Susan

AU - Wu, Howard

AU - Wang, Xiaoyan

AU - Cramer, Harvey

AU - Lin, Jingmei

AU - Chen, Shaoxiong

PY - 2014

Y1 - 2014

N2 - Objectives: The aim of this study is to determine the risk of neoplasm and malignancy in thyroid fine needle aspiration (FNA) diagnosed as atypia of undetermined significance with Hürthle cell change (AUS-H) or Hürthle cell neoplasm (HCN). Study Design: A computerized search of our laboratory information system was performed to identify all thyroid FNA and correlating surgical pathology diagnoses including Hürthle cell or oncocyte in the diagnostic nomenclature. The risks of neoplasm and malignancy were calculated for AUS-H and HCN categories separately. Results: For the 29 AUS-H cases, the follow-up histology demonstrated 15 benign lesions, 4 follicular adenomas, 7 Hürthle cell adenomas, 1 papillary microcarcinoma (PMC), 1 follicular carcinoma and 1 Hürthle cell carcinoma. For the 93 HCN cases, the follow-up histology demonstrated 28 benign lesions, 9 follicular adenomas, 32 Hürthle cell adenomas, 2 PMCs, 2 papillary thyroid carcinomas, 6 follicular carcinomas and 14 Hürthle cell carcinomas. Conclusions: The risks of neoplasm and malignancy were 62 and 7% for the AUS-H category and 73 and 24% for the HCN category, respectively. The risk of malignancy for the AUS-H patients is within the 5- to 15-percent range suggested by the Bethesda System for Reporting Thyroid Cytology and within the 15- to 30-percent range suggested for follicular neoplasms.

AB - Objectives: The aim of this study is to determine the risk of neoplasm and malignancy in thyroid fine needle aspiration (FNA) diagnosed as atypia of undetermined significance with Hürthle cell change (AUS-H) or Hürthle cell neoplasm (HCN). Study Design: A computerized search of our laboratory information system was performed to identify all thyroid FNA and correlating surgical pathology diagnoses including Hürthle cell or oncocyte in the diagnostic nomenclature. The risks of neoplasm and malignancy were calculated for AUS-H and HCN categories separately. Results: For the 29 AUS-H cases, the follow-up histology demonstrated 15 benign lesions, 4 follicular adenomas, 7 Hürthle cell adenomas, 1 papillary microcarcinoma (PMC), 1 follicular carcinoma and 1 Hürthle cell carcinoma. For the 93 HCN cases, the follow-up histology demonstrated 28 benign lesions, 9 follicular adenomas, 32 Hürthle cell adenomas, 2 PMCs, 2 papillary thyroid carcinomas, 6 follicular carcinomas and 14 Hürthle cell carcinomas. Conclusions: The risks of neoplasm and malignancy were 62 and 7% for the AUS-H category and 73 and 24% for the HCN category, respectively. The risk of malignancy for the AUS-H patients is within the 5- to 15-percent range suggested by the Bethesda System for Reporting Thyroid Cytology and within the 15- to 30-percent range suggested for follicular neoplasms.

KW - Fine needle aspiration

KW - Hürthle cell neoplasm

KW - Risk of malignancy

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=84904065423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904065423&partnerID=8YFLogxK

U2 - 10.1159/000361073

DO - 10.1159/000361073

M3 - Article

C2 - 24819535

AN - SCOPUS:84904065423

VL - 58

SP - 235

EP - 238

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 3

ER -